The experience of application and outlook for antiandrogen treatment of paraphilias (analytical review)
Suggested citation:
Vvedenskiy GE, Basinskaya IA. [The experience of application and outlook for antiandrogen treatment of paraphilias (analytical review)]. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2013;(3):41-47. Russian
The paper discusses the basic issues of using antiandrogens in the treatment of paraphilias relying on data available from Russian and foreign literature, reviews the indications and contraindications for their use, side effects and efficacy.
1. Басинская И.А. Комплексное лечение лиц совершивших сексуальные правонарушения и оценка их общественной опасности: Автореф. дис. ... канд. мед. наук. - М., 2012. 2. Введенский Г.Е. Опыт применения антиандрогенов в лечении психически больных сексуальных правонарушителей // Тезисы Всерос. науч.-практ. конф. "Современные проблемы социальной и клинической сексологии". 13-15 сентября 2012. - Казань, 2012. - С. 287-288. 3. Возианов А.Ф., Резников А.Г., Клименко И.А. Принципы медикаментозной терапии рака предстательной железы // Пособие для врачей. - К., 2003. - 36 с. 4. Шредер Ф.Х., Вилан П., де Рейке М. и др. Метастатический рак простаты - рандомизированное исследование ципротерона ацетата в сравнении с флутамидом (EORTC 30892, окончательный анализ) // Материалы междунар. науч. конф. "Современные методы лечения рака предстательной железы". - К., 2002. - С. 19-20. 5. Amadeo M. Anti-androgen treatment of aggressivity in men suffering from dementia // J. Geriatr. Psychiatry Neurol. - 1996. - Vol. 9. - P. 142-145. 6. Berlin F.S., Meinecke C.F. Treatment of sex offenders with antiandrogenic medication: conceptualization, review of treatment modalities, and preliminary findings // Am. J. Psychiatry. - 1981. - Vol. 138. - P. 601-711. 7. Berlin F.S. Sex offenders: A biomedical perspective and a status report on biomedical treatment. The sexual aggressor: Current perspectives on treatment. - N.Y.: Van Nostrand Reinhold, 1983. 8. Berlin F.S. Sex offender treatment and legislation // J. Am. Acad. Psychiatry Law. - 2003. - Vol. 31. - P. 510-533. 9. Bradford J.M.W. The antiandrogen and hormonal treatment of sex offenders. Handbook of sexual assault: Issues, theories, and treatment of the offender. - N.Y.: Plenum Press, 1990. - Vol. 4. - P. 297-310. 10. Bradford J.M.W., Pawlak A. Effects of cyproterone acetate on sexual arousal patterns of pedophiles // Arch. Sex. Behav. - 1993. - Vol. 22. - P. 629-641. 11. Bradford J.M.W., Kaye N.S. Pharmacological treatment of sexual offenders // Am. Acad. Psychiatry Law Newslett. - 1999. - Vol. 24. - P. 16-17. 12. Bradford J.M.W. The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behavior // Can. J. Psychiatry. - 2001. - Vol. 46. - P. 26-34. 13. Brahams D. Voluntary chemical castration of a mental patient // Lancet. - 1988. - Vol. 31. - P. 1291-1292. 14. Briken P., Berner W., Noldus J. et al. Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRHagonist leuprolide acetate // Nervenarzt. - 2000. - Vol. 71. - P. 380-385. 15. Briken P., Nika E., Berner W. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists // J. Sex Marital Ther. - 2001. - Vol. 27. - P. 45-55. 16. Briken P., Hill A., Berner W. A relapse in pedophilic sex offending and subsequent suicide attempt during luteinizing hormone-releasing hormone treatment // J. Clin. Psychiatry. - 2004. - Vol. 65. - P. 1429-1434. 17. Briken P., Welzel K., Habermann N. et al. Antiandrogenic pharmacotherapy of sexual offenders and home leave steps in the forensic psychiatric hospital Berlin // Psychiatr. Prax. - 2009. - Vol. 36. - P. 232-237. 18. Conn P.M., Crowley W.F.Jr. Gonadotropin-releasing hormone and its analogues // N. Engl. J. Med. - 1990. - Vol. 324. - P. 93-103. 19. Cooper A.J. Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia // J. Clin. Psychiatry. - 1987. - Vol. 48. - P. 368-370. 20. Cooper A.J., Sandhu S., Losztyn S. A double-blind placebo controlled trial of medroxyprogestrone acetate and cyproterone acetate with seven pedophiles // Can. J. Psychiatry. - 1992. - Vol. 37. - P. 33-39. 21. Cordier B., Thibaut F., Kuhn J.M. et al. Hormonal treatments for disorders of sexual conduct // Bull. Acad. Natl Med. - 1996. - Vol. 180. - P. 599-605. 22. Czerny J.P., Briken Р., Berner W. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics // Eur. Psychiatry. - 2002. - Vol. 17. - P. 104-106. 23. Dickey R. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist // Can. J. Psychiatry. - 1992. - Vol. 37. - P. 567-569. 24. Dickey R. Case report: the management of bone demineralization associated with long term treatment of multiple paraphilia with long acting LHRH agonists // J. Sex Marital Ther. - 2002. - Vol. 28. - P. 207-210. 25. Gallagher J.C., Rapuri P.B. Osteoporosis: Pathophysiology. Encyclopedia of hormones. - San Diego, CA: Academic Press, 2003. - Vol. 3. - P. 89-98. 26. Gijs L.,Gooren L. Hormonal and psychopharmacological interventions in the treatment of paraphilias: An update // J. Sex Res. - 1996. - Vol. 33. - P. 273-290. 27. Giltay E.J., Gooren L.J. Potential side effects of androgen deprivation treatment in sex offenders // J. Am. Acad. Psychiatry Law. - 2009. - Vol. 37. - P. 53-58. 28. Gooren L.J., Lips P., Gijs L. Osteoporosis and androgendepleting drugs in sex offenders // J. Forensic Sci. - 2001. - Vol. 357. - P. 1208-1209. 29. Gordon H., Grubin D. Psychiatric aspects of the assessment and treatment of sex offenders // Royal College of Psychiatrists. - 2004. - Vol. 10. - P. 73-80. 30. Gottesman H.G, Schubert D.S. Low-dose oral medroxyprogesterone acetate in the management of the paraphilias // J. Clin. Psychiatry. - 1993. - Vol. 54. - P. 182-188. 31. Grasswick L.J, Bradford J.M.W. Osteoporosis associated with the treatment of paraphilias: A clinical review of seven case reports // J. Forensic Sci. - 2003. - Vol. 48. - P. 8 4 9 - 8 5 5 . 32. Grossman L.S., Gordon C., Hall N. et al. Sexual Offender Recidivism Revisited: A Meta-Analysis of Recent Treatment Studies // J. Consult. Clin. Psychol. - 1995. - Vol. 63. - P. 806-808. 33. Grossman L.S., Martis B., Fichtner C.G. Are Sex Offenders Treatable? A Research Overview // Psychiatr. Serv. - 1999. - Vol. 50. - P. 351-359. 34. Hansen H., Lykke-Olesen L. Treatment of dangerous sexual offenders in Denmark // J. Forensic Psychiatry. - 1997. - Vol. 8. - P. 195-199. 35. Haussermann P., Goecker D., Beier K. et al. Low-dose cyproterone acetate treatment of sexual acting out in men with dementia // Int. Psychogeriatr. - 2003. - Vol. 15. - P. 181-186. 36. Hebebrand K., Hebebrand J., Remschmidt H. Pharmacological agents for treatment of paraphilias and hypersexual disorders // Fortschr. Neurol. Psychiatr. - 2002. - Vol. 70, N 9. - P. 4 6 2 - 47 5 . 37. Higano C.S. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity // Urology. - 2003. - Vol. 61. - P. 32-38. 38. Hill A., Briken P., Kraus C. et al. Differential pharmacological treatment of paraphilias and sex offenders // Int. J. Offender Ther. Comp. Criminol. - 2003. - Vol. 47. - P. 407-421. 39. Hoogeveen G.H, Van Der Veer E. Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia // J. Sex Med. - 2008. - Vol. 5. - P. 626-630. 40. Kafka M.P. Therapy for Sexual Impulsivity: The Paraphilias and Paraphilia-Related Disorders // Psychiatr. Times. - 1996. - Vol. 13. - P. 6-16. 41. Kravitz H.M., Haywood T. W., Kelly J. et al. Medroxyprogesterone and paraphiles: do testosterone levels matter? // Bull. Am. Acad. Psychiatry Law. - 1996. - Vol. 24. - P. 73-83. 42. Krueger R.B., Kaplan M.S. Depot-leuprolide acetate for treatment of paraphilias: a report of twelve cases // Arch. Sex. Behav. - 2001. - Vol. 30. - P. 409-422. 43. Krueger R.B., Kaplan M.S. Behavioral and psychopharmacological treatment of the paraphilic and hypersexual disorders // J. Psychiatr. Pract. - 2002. - Vol. 8. - P. 21-32. 44. Krueger R.B., Hembree W., Hill M. Prescription of medroxyprogesterone acetate to a patient with pedophilia, resulting in Cushing syndrome and adrenal insufficiency // Sex. Abuse. - 2006. - Vol. 18. - P. 227-228. 45. Kumar R.J., Barqawi A., Crawford E.D. Preventing and treating the complications of hormone therapy // Curr. Urol. Rep. - 2005. - Vol. 6. - P. 217-223. 46. Laron Z., Kauli R. Experience with the cyproterone acetate in the treatment of precocious puberty // J. Pediatr. Endocrinol. Metab. - 2000. - Vol. 13. - P. 805-810. 47. Levitsky A.M., Owens, N.J. Pharmacologic treatment of hypersexuality and paraphilias in nursing home residents // J. Am. Geriatr. Soc. - 1999. - Vol. 47. - P. 231-234. 48. Light S.A., Holroyd S. The use of medroxyprogesterone acetate for the treatment of sexually inappropriate behavior in patients with dementia // J. Psychiatry Neurosci. - 2006. - Vol. 31. - P. 132-134. 49. Maletzky B.M. Treating the sexual offender. - Newbury Park, CA: Sage, 1991. - Vol. 7. - P. 16-25. 50. Meyer W.J., Cole C.M., Emory E. Depo provera treatment of sex offending behavior: an evaluation of outcome // Bull. Am. Acad. Psychiatry Law. - 1992a. - Vol. 20. - P. 249-259. 51. Neumann F. Pharmacological basis for clinical use of antiandrogens // J. Steroid Biochem. - 1983. - Vol. 19. - P. 3 9 1- 3 4 0 . 52. Neumann F., Kalmus J. Cyproterone acetate in the treatment of sexual disorders: pharmacological base and clinical experience // Exp. Clin. Endocrinol. - 1991. - Vol. 98. - P. 71-80. 53. Neumann R. Pharmacology and potential use of cyproterone acetate // Horm. Metab. Res. - 1997. - Vol. 9. - P. 1-13. 54. O’Connell M.B., Seaton T.L. Osteoporosis and osteomalacia // Pharmacotherapy: Apathophysiologic approach. - N.Y.: McGraw-Hill, 2005. - Vol. 6. - P. 1645-1669. 55. Ott B.R. Leuprolide treatment of sexual aggression in a patient with dementia and the Kluver-Bucy syndrome // Clin. Neuropharmacol. - 1995. - Vol. 18. - P. 443-447. 56. Pavone-Macaluso M., de Voogt H.J., Viggiano G. et al. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group // J. Urol. - 1986. - Vol. 136. - P. 6 24 - 6 3 1. 57. Prentky R.A. Arousal reduction in sexual offenders: A review of antiandrogen interventions // Sex. Abuse: A Journal of Research and Treatment. - 1997. - Vol. 9. - P. 335-349. 58. Reilly D.R., Delva N.J., Hudson R.W. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia // Can. J. Psychiatry. - 2000. - Vol. 45. - P. 559-563. 59. Rich S.S., Ovsiew F. Leuprolide acetate for exhibitionism in Huntington’s disease // Mov. Disord. - 1994. - Vol. 9. - P. 353-357. 60. Richer M., Crismon M.L. Pharmacotherapy of sexual offenders // Ann. Pharmacother. - 1993. - Vol. 27. - P. 316-320. 61. Rцsler A., Witztum E. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone // N. Engl. J. Med. - 1998. - Vol. 338. - P. 416-422. 62. Rцsler A., Witztum E. Pharmacotherapy of paraphilias in the next millennium // Behav. Sci. Law. - 2000. - Vol. 18. - P. 4 3 - 5 6 . 63. Rousseau L., Couture M., Dupont A. et al. Effect of combined androgen blockade with an LHRH agonist and fl utamide in one severe case of male exhibitionism // Can. J. Psychiatry. - 1990. - Vol. 35. - P. 338-341. 64. Saleh F.M., Guidry L.L. Psychosocial and biological treatment considerations for the paraphilic and nonparaphilic sex offender // J. Am. Acad. Psychiatry Law. - 2003. - Vol. 31. - P. 4 8 6 - 4 9 3 . 65. Saleh F.M., Berlin F.S. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders // J. Child Sex. Abus. - 2003. - Vol. 12. - P. 2 3 3 - 2 5 3 . 66. Saleh F.M., Niel T., Fishman M.J. Treatment of paraphilia in young adults with leuprolide acetate: A preliminary case report series // J. Forensic Sci. - 2004. - Vol. 49. - P. 1-6. 67. Saleh F.M. Serotonin reuptake inhibitors and the paraphilias // Am. Acad. Psychiatry Law Newslett. - 2004. - Vol. 23. - P. 12 -13 . 68. Saleh F.M. A hypersexual paraphilic patient treated with leuprolide acetate: a single case report // J. Sex Marital Ther. - 2005. - Vol. 31. - P. 433-444. 69. Schneider H.P. Androgens and antiandrogens // Ann. N.Y. Acad. Sci. - 2003. - Vol. 997. - P. 292-306. 70. Schober J.M., Byrne P., Kuhn P.J. Leuprolide acetate is a familiar drug that may modify sex-offender behaviour: the urologist’s role // BJU Int. - 2006. - Vol. 97. - P. 684-686. 71. Schober J.M., Kuhn P.J., Kovacs P.G. et al. Leuprolide acetate suppresses pedophilic urges and arousability // Arch. Sex. Behav. - 2005. - Vol. 34. - P. 691-705. 72. Series H., Dйgano P. Advances in Psychiatric Treatment // J. Forensic Psychiatry. - 2005. - Vol. 11. - P. 424-431. 73. Smith M.R. Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma // Cancer Suppl. - 2003. - Vol. 97. - P. 789-795. 74. Stewart J.T. Optimizing antilibidinal treatment with medroxyprogesterone acetate // J. Am. Geriatr. Soc. - 2005. - Vol. 53 - P. 3 5 9 - 3 6 0 . 75. Thibaut F., Cordier B., Kuhn J.M. Effect of a long-acting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia // Acta Psychiatr. Scand. - 1993. - Vol. 87. - P. 445-450. 76. Thibaut F., Kuhn J.M., Cordier B. et al. Hormone treatment of sex offenses // J. Am. Geriatr. Soc. - 1998. - Vol. 24. - P. 132-137. 77. Volavka J. Neurobiology of violence. - Washington, DC: American Psychiatric Press, 1995. 78. Walker P., Meyer W.J. Medroxyprogesterone acetate for paraphiliac sex offenders. - N.Y.: SP Medical and Scientific Books, 1981. - Vol. 32. - P. 103-110. 79. Weiner M.F., Denke M., Williams K. et al. Intramuscular medroxyprogesterone acetate for sexual aggression in elderly men // Lancet. - 1992. - Vol. 339. - P. 1121-1122. 80. Wilke D.R., Parker C., Andonowski A. et al. Testosterone and erectile function recovery after radiotherapy and long-term androgen deprivation with luteinizing hormone-releasing hormone agonists // BJU Int. - 2006. - Vol. 97. - P. 963-968.
DOI: http://dx.doi.org/10.24411/1560-957X-2013-11334
Article Metrics
Metrics powered by PLOS ALM